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http:WHAT THIS PAPER ADDS
Perioperative cranial nerve palsy remains an important complication of carotid endarterectomy, and occurred in
5.5% of patients in a recent large randomized trial. There is a signiﬁcant association between the occurrence of
perioperative haematoma and perioperative cranial nerve palsy. Patients can be reassured that many cranial
nerve palsies following carotid endarterectomy are transient and non-disabling. Women should be warned
about an increased risk of cranial nerve palsy.Objective: Cranial nerve palsy (CNP) and neck haematoma are complications of carotid endarterectomy (CEA).
The effects of patient factors and surgical technique were analysed on the risk, and impact on disability, of CNP or
haematoma in the surgical arm of the International Carotid Stenting Study (ICSS), a randomized controlled clinical
trial of stenting versus CEA in patients with symptomatic carotid stenosis.
Materials and methods: A per-protocol analysis of early outcome in patients receiving CEA in ICSS is reported.
Haematoma was deﬁned by the surgeon. CNP was conﬁrmed by an independent neurologist. Factors associated
with the risk of CNP and haematoma were investigated in a binomial regression analysis.
Results: Of the patients undergoing CEA, 45/821 (5.5%) developed CNP, one of which was disabling (modiﬁed
Rankin score ¼ 3 at 1 month). Twenty-eight (3.4%) developed severe haematoma. Twelve patients with
haematoma also had CNP, a signiﬁcant association (p < .01). Independent risk factors modifying the risk of CNP
were cardiac failure (risk ratio [RR] 2.66, 95% CI 1.11 to 6.40), female sex (RR 1.80, 95% CI 1.02 to 3.20), the
degree of contralateral carotid stenosis, and time from randomization to treatment >14 days (RR 3.33, 95% CI
1.05 to 10.57). The risk of haematoma was increased in women, by the prescription of anticoagulant drugs pre-
procedure and in patients with atrial ﬁbrillation, and was decreased in patients in whom a shunt was used and in
those with a higher baseline cholesterol level.
Conclusions: CNP remains relatively common after CEA, but is rarely disabling. Women should be warned about
an increased risk. Attention to haemostasis might reduce the incidence of CNP. ICSS is a registered clinical trial:
ISRCTN 25337470.
 2014 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Evidence from randomized trials of medical therapy versus
carotid endarterectomy (CEA) for symptomatic stenosis of the
carotid artery1 has led to the recommendation that CEA
should be performed in patients with symptomatic carotid
artery stenosis to reduce the long-term risk of recurrent stroke
or TIA.2 The combined rate of stroke or death at 30 days
followingCEA inNASCET, ECST, and theVA trialswas 7.1% (95%
CI 6.3 to 8.1%).3 However, the primary endpoints of these trials
did not include cranial nerve palsy (CNP) or haematoma.
CNP and Haematoma after Endarterectomy 499Although less extensively studied, the surgical complications of
CNP and haematoma have long been recognized following
CEA,4 andhavebeen associatedwith an increased riskof stroke
or death.5 Nerves affected include the mandibular branch of
the facial nerve, vagal, glossopharyngeal, hypoglossal, and
accessory nerves,4,6,7 and therefore CNP has the potential to
cause signiﬁcant postoperative morbidity.
Carotid angioplasty and stenting (CAS) was developed as
an alternative to CEA, in part to avoid these hazards of a
surgical incision. However, the results of recent large ran-
domized trials, including the International Carotid Stenting
Study (ICSS),8 have consistently shown that CAS carries a
higher risk of non-disabling stroke than CEA within 30 days
of the procedure, with no signiﬁcant difference in the rates
of disabling stroke or death.9 ICSS was a randomized
controlled multicentre open clinical trial that randomized
patients with symptomatic carotid stenosis to CEA or CAS.
In this study, the incidence and severity of CNP and hae-
matoma in ICSS, and risk factors for their development,
were studied, to identify groups of patients at higher risk
and determine whether these complications merit consid-
eration in selection of a revascularization procedure.METHODS
Study design
Patient selection and protocol design. The protocol for ICSS
is published elsewhere.10 Patients over 40 years old were
eligible for randomization in ICSS if they had more than 50%
recently symptomatic carotid stenosis suitable for either
CAS or CEA, and were clinically stable. Patients were
excluded if they had a major stroke with poor recovery of
function, if their vascular anatomy rendered CAS or CEA
unsuitable, if the stenosis was caused by non-atheromatous
disease, if cardiac bypass was planned within 1 month of
the revascularization procedure, or if there had been pre-
vious revascularization of the symptomatic artery.
Carotid endarterectomy in ICSSwas performed according to
the surgeon’s usual practice: local, general, or combined
anaesthesiawas allowed for the procedure.The typeof arterial
reconstruction to be carried out was not speciﬁed in the
protocol, nor was the choice of peri-procedural medication.
Outcome events. Technical details of the surgical procedure
and the occurrence of cranial nerve palsy or haematoma wereTable 1. Summary of cranial nerve palsies (CNPs) within 30 days o
procedure was initiated (n ¼ 821).
Cranial nerve Number of CNPs
(n ¼ 50 in 45 patients)
Nu
(m
Facial 23 0
Hypoglossal 13 0
Vagus 6 0
Accessory 1 0
Glossopharyngeal 4 1
Trigeminal 1 0
Undetermined 2 0
CNP ¼ cranial nerve palsy; ICSS ¼ International Carotid Stenting Studreported by trial investigators. All patients were then re-
assessed at 1 month after the procedure by a neurologist or
investigator under their supervision. CNPs were adjudicated
internally at the ICSS trial ofﬁce and judged to be disabling if
the patient’s score on the modiﬁed Rankin Scale (mRS)
increased to 3 or more at 30 days after the procedure, where
that increase was attributable to the CNP. Investigators were
additionally asked to complete a questionnaire (Appendix I)
giving details of the clinical consequences of CNP and whether
or not the lesion resolved during subsequent follow-up in the
trial. Haematoma was classiﬁed as severe if it required re-
operation, transfusion, or prolonged hospital stay.
Statistical analysis. The data were analysed per-protocol;
only patients in whom the randomly allocated procedure
was initiated were included in this analysis. Patients who
crossed over or received CEA after an attempt at stenting
were excluded. A procedure was deemed to have been
initiated if the patient underwent either local or general
anaesthesia prior to commencement of surgery. Risk factors
for CNP and haematoma were examined sequentially in a
univariable binomial regression analysis using maximum
likelihood estimation. The risk ratio for each factor was
estimated with a 95% conﬁdence interval. Wald tests were
used for continuous and binary predictors, with an overall
likelihood ratio test for categorical predictors of more than
two levels. A multivariable model was developed using a
forward stepwise based approach. Patients with missing
data were excluded from each relevant analysis. Analyses
were performed with Stata (StataCorp. 2011. Stata Statisti-
cal Software: Release 12. College Station, TX: StataCorp LP).RESULTS
Cranial nerve palsy
In ICSS, 1713 patients were randomized. Of 858 patients
randomized to CEA, the allocated procedure was initiated in
821 (95.7%). Four of 821 patients (0.5%) died between
initiation of the procedure and 30 days post-procedure.
Forty-ﬁve of 821 patients (5.5% of initiated CEAs) were
reported to have CNP within 30 days of the procedure. The
results of adjudication of which cranial nerves were
affected are presented in Table 1. A total of 50 CNPs were
reported: facial (n ¼ 23), vagus (6), hypoglossal (13),
glossopharyngeal (4), accessory (1), and trigeminal (1); inf endarterectomy in ICSS per-protocol participants in whom the
mber of disabling CNPs
RS  3 because of CNP)
Number of CNPs conﬁrmed
persisting after 30 days
4
2
4
0
1
0
0
y; mRS ¼ modiﬁed Rankin Scale score.
Figure 1. Univariable predictors of risk of cranial nerve palsy within 30 days of endarterectomy in ICSS per-protocol participants in whom
the procedure was initiated (n¼821).
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Figure 1. (continued).
CNP and Haematoma after Endarterectomy 501two patients it was not possible to determine which cranial
nerve was affected. One CNP was judged to be disabling
with an mRS of 3 at 1-month follow-up. This patient had
glossopharyngeal nerve palsy with impairment in swallow-
ing requiring placement of a naso-gastric feeding tube. Two
cranial nerve palsies were reported in each of ﬁve trial
participants. In those patients with CNP where symptom-
atic resolution was conﬁrmed (n ¼ 20), the median dura-
tion of symptoms before resolution was 30 days (minimum
2 days, maximum 520 days). The exact duration of symp-
toms in the remainder was undetermined. In only two ofTable 2. Independent predictors of risk of cranial nerve palsy within 3
(n ¼ 805) in whom the procedure was initiated. Patients with missing
Variable
Cardiac failure
Female sex
Time from randomization to treatment >14 days
Degree of contralateral stenosis
0e50%
50e69%
>70%821 patients (0.2%) were the symptoms reported to have
not resolved during follow-up of 6.4 and 3.1 years,
respectively. One of these patients experienced voice
hoarseness caused by vocal cord paresis following vagal
nerve injury. The other experienced uplifting of the mouth
on one side as a result of facial nerve injury.
The results of the risk factor analysis are presented in
Fig. 1. Statistically signiﬁcant predictors of CNP in uni-
variable analysis were female sex (risk ratio [RR] 1.90, 95%
CI 1.08 to 3.36, p ¼ .03) and a high degree of contralateral
carotid artery stenosis. Other demographic and technical0 days of carotid endarterectomy in ICSS per-protocol participants
data were excluded from this analysis.
Adjusted risk ratio (95% CI) Adjusted p value
2.66 (1.11 to 6.40) .03
1.80 (1.02 to 3.20) .04
3.33 (1.05 to 10.57) .04
Overall p < .01
1.00
1.18 (0.62 to 2.27) .62
0.13 (0.02 to 0.91) .04
Table 3. Numbers (%) of patients with haematoma by presence of
cranial nerve palsy (CNP)a within 30 days of carotid
endarterectomy in ICSS per-protocol participants (n¼821).
Haematoma
Number (%) Yes (%) Total (%)
CNP No (%) 738 (95.1) 38 (4.9) 776 (100)
Yes (%) 33 (73.3) 12 (26.7) 45 (100)
Total 771 50 821
a p < .01 by Fisher’s exact test of independence between hae-
matoma and CNP.
502 D. Doig et al.factors, including the type of arterial reconstruction, type of
anaesthesia or shunt use did not predict CNP. Independent
predictors of CNP in multivariable analysis, summarised in
Table 2, were cardiac failure (RR 2.66, 95% CI 1.11 to 6.40,
p ¼ .03), female sex (RR 1.80, 95% CI 1.02 to 3.20, p ¼ .04),
the degree of contralateral carotid stenosis, and time to
operation of >14 days after the day of randomization (RR
3.33, 95% CI 1.05 to 10.57, p ¼ .04).
Haematoma
Of 821 patients in whom the surgical procedure was initi-
ated, 50 (6.1%) developed neck haematoma. Twenty-eight
of the 821 (3.4%) were classiﬁed as severe.
The results of univariable regression analysis for the risk
factors for haematoma development are presented in
Appendix II. Statistically signiﬁcant predictors of increased
risk of haematoma were: anticoagulant prescription pre-
operatively (RR 1.83, 95% CI 1.04 to 3.23, p ¼ .04), previous
cardiac bypass graft surgery (CABG) (RR 2.46, 95% CI 1.37 to
4.42, p < .01), atrial ﬁbrillation (RR 2.29, 95% CI 1.08 to
4.85, p ¼ .03), and the duration of arterial clamping in
minutes (RR per each extra 20 minutes 1.13, 95% CI 1.04 to
1.24, p < .01). Factors associated with a decreased risk of
postoperative haematoma were shunt use (RR 0.54, 95% CI
0.29 to 0.99, p ¼ .05), antiplatelet agent prescription prior
to the procedure (RR 0.44, 95% CI 0.21 to 0.93, p ¼ .03) and
each 1 mmol/l increase in cholesterol at baseline (RR 0.69,
95% CI 0.55 to 0.88, p < .01). Other demographic and
technical factors did not predict haematoma.
The results of multivariable analysis of predictors of risk
for haematoma are presented in Appendix III. Independent
predictors of increased risk were being female (RR 2.03,
95% CI 1.13 to 3.62, p ¼ .02), having atrial ﬁbrillation (RR
2.38, 95% CI 1.07 to 5.27, p ¼ .03), and the prescription of
anticoagulant pre-procedure (RR 1.86, 95% CI 1.01 to 3.42,
p ¼ .05). Independent factors reducing the risk ofTable 4. Composite outcome events within 30 days of carotid stenting
the addition of cranial nerve palsy (CNP), in per-protocol participants.
Endpoint CAS (n ¼ 828)
No. events (%)
CEA (n ¼ 821)
No. events (%)
Stroke, MI or deatha 61 (7.4%) 33 (4.0%)
Stroke, MI, death or CNP 62 (7.5%) 76 (9.3%)
Disabling stroke or death 26 (3.1%) 18 (2.2%)
Disabling stroke, disabling
CNP or death
27 (3.3%) 19 (2.3%)
a Reported in Lancet 2010;376:985e997.haematoma were shunt use (RR 0.40, 95% CI 0.21 to 0.80,
p < .01) and each 1 mmol/l increase in the patient’s
baseline cholesterol level (RR 0.68, 95% CI 0.54 to 0.86,
p < .01).
Twelve of 45 (26.7%) patients with CNP also suffered
haematoma, versus 38/776 (4/9%) of patients without CNP.
There was a signiﬁcant association between these compli-
cations as detailed in Table 3 (p < .01, Fisher’s exact test).Impact on trial outcomes
Table 4 details the impact of adding CNP to the combined
incidence of stroke, myocardial infarction (MI), or death in
ICSS in a post-hoc analysis comparing CEA with CAS. There
was no signiﬁcant difference in the combined risk of stroke,
MI, death, or CNP, nor was there a signiﬁcant difference in
the incidence of disabling stroke, disabling CNP, or death
between the two trial arms.DISCUSSION
In ICSS, CNP developed in 5.5% of ICSS patients undergoing
CEA, and haematoma in 6.1%. There was a statistically sig-
niﬁcant association between the two outcomes. The largest
available series of patients studied pre- and post-
operatively, in the European Carotid Surgery Trial (ECST),
found a motor CNP rate of 5.1% and a long-term CNP rate
of 0.5% at 4 months.11 Likewise, NASCET reported an overall
risk of postoperative CNP of 8.6%, of which the majority
were mild in severity,12 suggesting that CNP rates remain
constant over time.
Patients should be made aware of these common com-
plications and the likely clinical effects, including sensory
and possible motor consequences. They can be reassured
from the evidence presented here that postoperative CNP is
rarely disabling (risk around 1 in 1000 operations), but
should be warned that the symptoms of the CNP may
persist for several weeks or longer.
There are several other ﬁndings of interest from this
study: to the authors’ knowledge, the association between
female sex and CNP has not previously been described, and
this ﬁnding is worth conﬁrming in another cohort of pa-
tients. One possible explanation for higher risk in female
patients may be more challenging surgical anatomy and the
smaller average diameter of the carotid artery.13 Female
patients were also at higher risk of haematoma. Combined
with other reports of a higher perioperative stroke risk in(CAS) versus carotid endarterectomy (CEA) in ICSS, with or without
Risk ratio
(95% CI)
Risk difference
(95% CI)
p
(chi-square)
1.83 (1.21, 2.77) 3.3% (1.1, 5.6) <.01
0.81 (0.59, 1.12) 1.8% (4.4, 0.9) .20
1.43 (0.79, 2.59) 0.9% (0.6, 2.5) .23
1.41 (0.79, 2.51) 0.9% (0.6, 2.5) .24
CNP and Haematoma after Endarterectomy 503symptomatic women undergoing CEA versus men,14 and
evidence that the net beneﬁt of CEA in women is lower
than in men,15 an increased incidence of CNP should be
borne in mind when advising female patients of their risk of
complications following CEA.
Other risk factors for CNP identiﬁed in this analysis,
including the degree of contralateral carotid stenosis, are
statistically signiﬁcant predictors but are more difﬁcult to
link clinically with the outcome and have not, to the au-
thors’ knowledge, been reported by other groups.
The association of neck haematoma with pre-operative
anticoagulation is not surprising, but emphasizes the
importance of careful surgical technique to mitigate the risk
of haematoma in anticoagulated patients. A risk of hae-
matoma in ICSS of 6.1% is similar to the rate of “wound
complications” seen in large case series16 and a severe
haematoma risk of 3.4% is similar to the reported risk of re-
exploration of the surgical wound required in patients un-
dergoing CEA while on antiplatelet medication.17 However,
although there is concern about perioperative bleeding in
patients on dual antiplatelet therapy, the incidence of
haematoma was actually decreased in this study in patients
taking these medications, perhaps because surgeons took
more care with haemostasis in these patients.
Some systematic reviews have included CNP in a com-
posite outcome event of death or neurological complications
up to 30 days after treatment.18 ICSS compared CAS with CEA
on the assumption that if CAS could avoid neck incision, CNP,
and haematoma with no excess risk of stroke, then it could
provide a beneﬁcial alternative to CEA for the prevention of
recurrent stroke in patients with symptomatic carotid ste-
nosis.10 In ICSS, as reported here, the total number of events
in the composite cluster of any stroke, MI, death, or CNP was
greater after CEA compared with CAS, but the numbers in
the cluster of disabling stroke, disabling CNP or death were
greater after CAS than after CEA. Neither difference was
statistically signiﬁcant. It is concluded, therefore, that it
would not be appropriate to base treatment considerations
concerning the choice of CAS versus CEA on the basis of
composite short-term endpoints including CNP.
Limitations of the analysis
The present analysis has some important limitations. In
some patients, information regarding baseline risk factors
was unavailable, and information about the duration of CNP
symptoms was limited. Multiple comparisons without sta-
tistical correction raise the possibility of obtaining a Type I
(false positive) error. Results could be conﬁrmed in other
patient cohorts. This is not a randomized comparison of
surgical techniques or perioperative processes of care, and
it is possible that unmeasured confounders are associated
with the risk of CNP or haematoma.
Conclusion
CNP remains a relatively common complication of CEA, but
in many patients is transient. Haematoma is similarly
common, and there is a statistical association betweenhaematoma and CNP. Women should be warned about an
increased risk of CNP. Scrupulous attention to haemostasis
might reduce the incidence of CNP. Fortunately, prolonged
disability or permanent symptoms as a result of haematoma
or CNP are rare, and thus, in the authors’ opinion, do not
warrant inclusion in composite endpoints for future trials of
carotid revascularization, but nevertheless one in 821 CEA
patients in ICSS had permanent impairment of swallowing
caused by cranial nerve palsy.
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